Share ownership Nanologica AB

NICA

SE0005454873

Commodity Chemicals

Market Closed - Nasdaq Stockholm Other stock markets 11:29:51 2025-07-15 am EDT			5-day change	1st Jan Change
1.135 ^SEK	-5.42%		+4.13%	-37.64%

Jul. 10	Nanologica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
Jul. 10	Nanologica Increases Revenue but Reports Wider Operating Loss	FW

Share class: Nanologica AB

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	44,178,618	43,736,832 ( 99 %)	0	99 %

Major shareholders: Nanologica AB

Name	Equities	%	Valuation
FCG Fonder AB 0.2807 %	248,019	0.2807 %	30 189 kr

Breakdown by shareholder type

Institutional	0.28%
Unknown	99.72%

Based on 1000 largest holdings

Geographical origin of shareholders

Sweden

0.28%

Based on 1000 largest holdings

Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)âs drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.

Employees

Sector

Commodity Chemicals

Calendar

Oct. 22 - Q3 2025 Earnings Release

More about the company